Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection.

Srinivasan Rajsri, Kritika; Roy, Nainita; Chakraborty, Sohini

Srinivasan Rajsri, Kritika; Roy, Nainita; Chakraborty, Sohini.

Afiliación

Srinivasan Rajsri K; Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Roy N; Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY 10010, USA.
Chakraborty S; Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA.

Cancers (Basel) ; 15(10)2023 May 22.

Article en En | MEDLINE | ID: mdl-37345204

Palabras clave

acute myeloid leukemia (AML); blasts; immunophenotype; leukemia stem cells (LSCs); measurable/minimal residual disease (MRD); multiparametric flow cytometry (MFC); relapse

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google